Tiratricol sodiumProduct ingredient for Tiratricol

Name: Tiratricol sodium
Drug Entry: Tiratricol

Tiratricol is an analogue and active metabolite of the thyroid hormone triiodothyronine (T3).⁹ It was first approved by the EMA on February 12, 2025 for the treatment of peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency,¹ a disorder characterized by chronic tissue thyrotoxicosis and abnormal neuronal development due to the impaired thyroid hormone uptake in the brain.⁸ Tiratricol is currently being investigated in US clinical trials.

See full entry for Tiratricol
Accession Number: DBSALT002405
Structure: MOL SDF PDB SMILES InChI
Structure for Tiratricol sodium (DBSALT002405)
Synonyms: SODIUM 4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYLACETATE